Composition for suppressing increase in blood sugar level and increase in blood triglyceride
Through the combination of camellia extract, mulberry leaf extract and chitosan, the inhibitory effect of camellia saponin and α-glucosidase was used to solve the problem of postprandial blood sugar and triglyceride rise, and achieved significant weight loss effect. It is suitable for Healthy auxiliary food.
Patent Information
- Application Number
- CN201980074183.2
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2019-12-16
- Publication Date
- 2024-11-29
- Estimated Expiration
- 2039-12-16
AI Technical Summary
Existing weight loss supplements are difficult to effectively inhibit the increase in post-meal blood sugar levels and triglycerides in the blood, and it is difficult to change dietary habits.
Using compositions of camellia extract, mulberry leaf extract and chitosan, the alpha-glucosidase inhibition of camellia saponin and mulberry leaf extract in camellia extract, as well as the adhesion and enzyme hindering of chitosan , jointly inhibit the rise of postprandial blood sugar and triglycerides.
It significantly inhibits the increase in postprandial blood sugar levels and triglycerides in the blood, provides unprecedented weight loss effects, and can be used in healthy auxiliary foods.
Smart Images

Figure CN112996523B_ABST
Abstract
Description
Technical Field
[0001] The present invention relates to a composition for suppressing the increase of postprandial blood sugar level and / or suppressing the increase of triglyceride in blood, characterized in that it contains camellia extract, mulberry leaf extract and chitosan as active ingredients. Background Art
[0002] Obesity often occurs after middle age. According to statistics, more than 30% of men aged 40-70 and 20-30% of women are obese. Obesity has been identified as increasing the risk of the three major causes of death, including cancer, heart disease, and cerebrovascular disease. Excessive intake of carbohydrates, greasy desserts, and increased intake of sweet drinks are considered to be the causes of obesity. In order to improve this diet, "dietary lifestyle guidelines" and "diet balance manuals" have been formulated, but it is particularly difficult to change eating habits.
[0003] Therefore, as a health supplement, weight loss supplements are widely used. As active ingredients formulated in weight loss supplements, chitosan, which has a glucose absorption inhibitory effect for the purpose of inhibiting the rise of postprandial blood sugar, and mulberry extract, which inhibits the decomposition of sugar-containing substances such as starch, can be cited.
[0004] Patent Document 1 describes a food for weight loss, which contains mulberry leaf extract and chitosan as useful ingredients. Mulberry leaf extract inhibits the rise of glucose in the blood by inhibiting α-glucosidase in the digestive tract and inhibiting the decomposition of starch into glucose. It is known that chitosan has α-glucosidase and α-amylase inhibitory effects in addition to inhibiting the absorption of sugary substances by adhering to the mucous membrane in the digestive tract.
[0005] In recent years, camellia extract has attracted much attention as a useful ingredient for weight loss. Camellia extract contains flavonoid glycosides unique to camellia, which can improve fat metabolism (Patent Document 2).
[0006] Patent document 3 describes a technique for extracting tea saponins from camellia. It is also known that saponins contained in camellia have various pharmacological effects, including antiallergic activity (Patent document 4), neutral fat absorption inhibition, gastric mucosal protection, sugar absorption inhibition (Patent document 5), intestinal hypermotility, prevention or improvement of intestinal obstruction or constipation, pancreatic lipase activity inhibition, free fatty acid production inhibition (Patent document 6), and gastric emptying function inhibition (Patent document 7).
[0007] Patent Literature
[0008] Patent Document 1: Japanese Patent Application Publication No. 2004-194635
[0009] Patent Document 2: Japanese Patent Application Publication No. 2011-051950
[0010] Patent Document 3: Japanese Patent Application Publication No. 2015-166326
[0011] Patent Document 4: Japanese Patent Application Publication No. 2008-024654
[0012] Patent Document 5: Japanese Patent Application Publication No. 2006-070018
[0013] Patent Document 6: Japanese Patent Application Publication No. 2009-057365
[0014] Patent Document 7: Japanese Patent Application Publication No. 2009-249374 Summary of the invention
[0015] The present inventors have discovered that a composition containing three ingredients, namely, mulberry leaf extract, chitosan and camellia extract, has an unprecedentedly strong effect of suppressing the increase in postprandial blood sugar levels and the increase in triglycerides in the blood, thereby completing the present invention.
[0016] That is, an object of the present invention is to provide a novel composition for suppressing an increase in postprandial blood sugar level and a composition for suppressing an increase in blood triglycerides.
[0017] The main structure of the present invention is as follows.
[0018] (1) A composition for suppressing a postprandial increase in blood sugar level and / or suppressing a postprandial increase in blood triglyceride, characterized in that it contains camellia extract, mulberry leaf extract and chitosan as active ingredients.
[0019] (2) The composition according to (1), characterized in that it contains 2 to 4 parts by mass of a dried mulberry leaf extract and 1 to 2 parts by mass of chitosan per 1 part by mass of a dried camellia extract.
[0020] (3) The composition according to (1) or (2), characterized in that it is to be consumed immediately before a meal.
[0021] (4) A composition for suppressing a postprandial increase in blood sugar level and / or suppressing a postprandial increase in blood triglycerides, characterized in that it contains 25 to 500 mg of a dried camellia extract, 50 to 1000 mg of a dried mulberry leaf extract, and 25 to 1000 mg of chitosan.
[0022] According to the present invention, a novel composition for inhibiting the increase of blood sugar level after a meal and a tablet or food containing the composition are provided. The composition of the present invention has the effect of reducing the blood sugar level that increases after a meal. In addition, for humans, the increase of triglycerides in the blood after a meal can also be inhibited. Therefore, it can be used in a supplement for weight loss, etc. BRIEF DESCRIPTION OF THE DRAWINGS
[0023] Figure 1 This is a graph showing the change over time in the blood glucose concentration of test animals in an animal test.
[0024] Figure 2 This is a graph showing the change over time of Δ in the blood glucose concentration of test animals in an animal test.
[0025] Figure 3 This is a graph showing the AUC of the blood glucose concentration of test animals in an animal test.
[0026] Figure 4 This is a graph showing ΔAUC of the blood glucose concentration of test animals in an animal test.
[0027] Figure 5 This is a graph showing the changes in blood sugar levels over time in human clinical trials (1).
[0028] Figure 6 This is a graph showing the temporal changes in blood insulin levels in a human clinical trial (1).
[0029] Figure 7 This is a graph showing the time-dependent changes in blood triglyceride (TG) levels in a human clinical trial (2). DETAILED DESCRIPTION
[0030] The present invention relates to a composition for suppressing a rise in postprandial blood sugar level and a tablet or food and drink containing the composition, which is characterized in that the composition contains camellia extract, mulberry leaf extract and chitosan as active ingredients.
[0031] In the present invention, the camellia used means the floral part of the tea plant (Camellia sinensis, also known as Thea sinensis) belonging to the genus Camellia (Camellia L.) of the Theaceae family (Theaceae), namely, the so-called flowers, flower buds and flower buds including pistils, stamens, petals, calyx, bracts, rachis, pedicels, etc.
[0032] In the present invention, the collected camellia flowers may be used directly, or may be dried and used, or may be prepared into tea by a method known to those skilled in the art.
[0033] (Camellia Extract)
[0034] The camellia extract in the present invention refers to an extract obtained by extracting the camellia with water or a water-soluble organic solvent and then removing the solvent, or an extract obtained by further extracting the camellia with a water-soluble solvent.
[0035] As the extraction technology for producing the camellia extract, the methods disclosed in Patent Documents 3 to 7 can be used. The details are as follows.
[0036] As for the extraction solvent used in the production of the camellia extract of the present invention, as the above-mentioned water-soluble organic solvent, a lower alcohol is preferred. As the lower alcohol, alcohols having 1 to 4 carbon atoms can be cited. Specifically, methanol, ethanol, n-propanol, isopropanol, n-butanol, isobutanol or tert-butanol or a mixture thereof, or an aqueous alcohol thereof in any proportion can be cited. It is preferred to use water or ethanol. It is further preferred to use water or about 80% ethanol, but in the present invention, the ethanol content of the aqueous ethanol is not particularly limited to 80%.
[0037] These extraction solvents are used in an amount of about 1 to 50 times (volume), preferably about 2 to 10 times (volume) the amount of the extraction material.
[0038] In addition, the extraction can be carried out under heating or at room temperature, and the extraction temperature can be set arbitrarily between room temperature and the boiling point of the solvent. In the case of extraction under heating, for example, it is more appropriate to immerse the flower part of Camellia in the above-mentioned extraction solvent under shaking (or stirring) or non-shaking or reflux at a temperature of 50°C to the boiling point of the extraction solvent. When the extraction material is immersed under shaking, it is appropriate to carry out for about 30 minutes to 5 hours, and when immersed under non-shaking, it is appropriate to carry out for about 1 hour to 20 days. In addition, when the extraction is carried out under reflux of the extraction solvent, it is preferably heated to reflux for 30 minutes to several hours.
[0039] Alternatively, the immersion and extraction may be performed at a temperature lower than 50° C. In this case, the immersion time is preferably longer than the above time. The extraction operation may be performed only once for the same material, but is preferably repeated multiple times, for example 2 to 5 times, from the viewpoint of extraction efficiency.
[0040] The extract obtained by filtering the solid matter after extraction is concentrated by a common method and used as an extract. The concentration is preferably carried out under reduced pressure. The concentration can be carried out until the extract is dry.
[0041] The extract can be used directly for preparing the composition of the present invention, or can be used in the present invention as a powder or freeze-dried dry extract. The method for preparing these solids can be a method known in the art.
[0042] The camellia extract of the present invention includes a concentrated dry solid or a freeze-dried product.
[0043] Furthermore, in the present invention, the extract obtained by concentrating the camellia extract can be subjected to partition extraction using a solvent, that is, partition extraction using water and a non-hydratable organic solvent can be performed once or multiple times to separate it into an organic solvent-soluble component and a water-soluble component.
[0044] Examples of the non-hydratable organic solvent include ethyl acetate, n-butanol, hexane, and chloroform. Among them, ethyl acetate is preferred.
[0045] That is, the water extract or aqueous lower alcohol extract of camellia is concentrated and the extract is partitioned with ethyl acetate and water as needed to obtain an ethyl acetate-soluble fraction and a water-soluble fraction.
[0046] Furthermore, the water-soluble component obtained above can be further subjected to partition extraction using water and a non-hydratable organic solvent to separate it into an organic solvent-soluble component and a water-soluble component.
[0047] Examples of the non-hydratable organic solvent in this case include n-butanol, hexane, and chloroform, and among them, n-butanol is preferred.
[0048] That is, the water-soluble fraction after the partition between ethyl acetate and water may be directly partitioned with n-butanol, or the residue obtained by concentrating the water-soluble fraction may be further partitioned with water and n-butanol to obtain an n-butanol-soluble fraction and a water-soluble fraction.
[0049] Camellia extract is also commercially available as a raw material for supplements, and the commercially available camellia extract can be used for the purpose of the present invention. As such commercially available camellia extract, "camellia dry extract (manufactured by Japan Pharmaceutical Food Research Institute Co., Ltd.)" can be exemplified. The camellia extract used in the present invention preferably contains 1.5% by mass or more of camellia saponins as total saponins.
[0050] The composition of the present invention is prepared so that the camellia extract is contained in an amount of 25 to 500 mg, preferably 50 to 250 mg, as a dried extract per person per intake.
[0051] (Mulberry Leaf Extract)
[0052] Mulberry leaves are leaves of plants of the genus Morus in the Moraceae family. In addition to being food for silkworms, they have also been used as tea since ancient times. Plants generally referred to as mulberries are represented by Mulberry (M. bombycis), Mulberry (M. laevigata), Mulberry (M. tiliaefolia), etc. In the present invention, commercially available products can be used for mulberry leaf extracts, which are sold by Nippon Shinyaku Co., Ltd., Toyotama Spice Co., Ltd., etc.
[0053] The mulberry leaf extract is preferably a hot water extract or a hydrous ethanol extract. For example, fresh or dried mulberry leaves are chopped and extracted in hot water for more than 15 minutes, followed by concentration and drying to obtain a powder. In addition, in the present invention, in addition to the aforementioned powder, the mulberry leaf extract may also be a concentrated liquid obtained without drying, a liquid extract obtained without concentration, etc.
[0054] The composition of the present invention is prepared so that the mulberry leaf extract is contained in an amount of 50 to 1000 mg, preferably 100 to 500 mg, as a dried extract per person per intake.
[0055] (Chitosan)
[0056] Chitosan is a type of polysaccharide, which refers to poly-β1→4-glucosamine. It is a linear polysaccharide and a 1,4-polymer of glucosamine, and is a high molecular weight substance with a molecular weight of thousands to hundreds of thousands.
[0057] As the chitosan used in the present invention, there can be cited substances obtained from the cell walls of crabs, shrimps, carapaces of insects, squids, mushrooms and filamentous fungi, etc. Preferred are substances obtained from the carapaces of crabs and shrimps. Chitosan is composed of glucosamine and acetylglucosamine, which can be dissolved in acidic water. The average molecular weight is usually more than 10,000, preferably the average molecular weight is more than 100,000, the rotational viscosity is more than 20mPa·s, and more preferably the average molecular weight is more than 800,000, and the rotational viscosity is more than 100mPa·s. In addition, the particle size of chitosan is not particularly limited, but it is preferably fine particles with a mesh size of less than 30, and more preferably less than 80 meshes. Chitosan is sold on the market as a raw material for weight loss food, for example, the product of Japan Chemical Food Technology Co., Ltd. can be used.
[0058] The composition of the present invention is formulated so that the chitosan is contained in an amount of 25 to 1000 mg, preferably 50 to 500 mg per person per intake.
[0059] The composition of the present invention is prepared so that 2 to 4 parts by mass of dried mulberry leaf extract and 1 to 2 parts by mass of chitosan are contained per 1 part by mass of dried camellia extract. By adopting such a mixing ratio, an effective effect of suppressing the increase of postprandial blood sugar level can be exerted.
[0060] In addition, when the inventors of the present invention evaluated based on animal experiments, the combination of the known mulberry leaf extract and chitosan showed a known level of postprandial blood sugar level rise inhibitory effect in the prior art. In addition, when the inventors of the present application tested the camellia extract known to have a blood sugar level rise inhibitory effect, they found that it did not play a postprandial blood sugar level rise inhibitory effect in animal experiments. However, the composition containing the three components of camellia extract, mulberry leaf extract, and chitosan showed an excellent postprandial blood sugar level rise inhibitory effect. Therefore, the composition prepared with the three components of camellia extract, mulberry leaf extract, and chitosan can play an unprecedented strong postprandial blood sugar level rise inhibitory effect.
[0061] Furthermore, the composition of the present invention can be formulated into food or drink, and is preferably ingested simultaneously with meals.
[0062] The composition of the present invention can be formulated into health foods or supplements directly or in the form of a formulation.
[0063] In addition, excipients or other active ingredients may be used in the formulation within the range that does not hinder the purpose of the composition of the present invention. Specifically, there are dietary fibers or thickeners such as cyclodextrin, hemicellulose, lignin, guar gum, konjac mannan, psyllium husk (Isabgol), alginic acid, agar, carrageenan, chitosan, carboxymethyl cellulose, polydextrose, edible oil, minerals such as calcium, iron, sodium, zinc, copper, potassium, phosphorus, magnesium, iodine, manganese, and selenium; fat-soluble or water-soluble vitamins such as vitamin A, vitamin C, vitamin D, vitamin E, vitamin K, niacin, folic acid, and pantothenic acid, glycerol fat Acid esters, sucrose fatty acid esters, sorbitan fatty acid esters, propylene glycol fatty acid esters, phospholipids, gum arabic, xanthan gum, tragacanth gum, locust bean gum and other emulsifiers or dispersants, extenders, excipients, preservatives, antioxidants, flavor regulators or spices, flavoring agents such as sodium chloride, monosodium glutamate, glycine, succinic acid, sodium lactate, citric acid, sodium citrate, acetic acid, adipic acid, fumaric acid, malic acid and other acidulants, low-calorie sweeteners such as maltitol and aspartame, coloring agents, etc.
[0064] Example
[0065] The present invention will be further described below by showing test examples using the composition of the present invention.
[0066] <1. Animal test to confirm the effect of suppressing the increase of blood sugar level after meal>
[0067] 1. Use of Animals
[0068] 40 male ddy mice were purchased, 8 weeks old at the start of the experiment, and were divided into 5 groups of 8 mice each after measuring their body weight so that there was no difference in body weight between the groups. After the animals were transported, they were acclimated for about one week, and fasted for more than 12 hours starting from the evening of the last day of the acclimation period.
[0069] 2. Commissioning test
[0070] Under fasting conditions, a solution of the test substance dissolved in distilled water was forcefully orally administered to the mice at 5 ml / kg, and then a sugar-containing substance (sucrose) was forcefully orally administered at 2 g / 5 mL / kg.
[0071] 3. Substances to be tested
[0072] The dosage groups and dosages of the tested substances are shown below.
[0073] (1) Control (distilled water 5 mL / kg)
[0074] (2) Chitosan 66.6 mg / kg + mulberry leaf extract (represented as "mulberry" in the figure) 133.44 mg / kg
[0075] (3) Camellia extract (referred to as “Camellia” in the figure) 39.96 mg / kg
[0076] (4) Chitosan 66.6 mg / kg + mulberry leaf extract 133.44 mg / kg + camellia extract 39.96 mg / kg
[0077] (5) Positive control: Acarbose 10 mg / kg
[0078] Acarbose used as a positive control is a drug for treating diabetes and is known to inhibit digestive enzymes required for carbohydrate digestion, particularly α-glucosidase secreted by the small intestine or α-amylase secreted by the pancreas, and suppress the increase in blood sugar levels after a meal.
[0079] The blending amounts of chitosan, mulberry leaf extract, and camellia extract are calculated and set so as to be three times the human equivalent volume (human body weight 53 kg) shown in Table 1 below.
[0080] [Table 1]
[0081] Chitosan 100mg Mulberry leaf extract (dried) 200mg Tea extract (dried) 60mg
[0082] 4. Post-meal blood sugar level measurement
[0083] On the day of the test, about 30 μL of blood was collected from the tail vein before administration of the above-mentioned test substance.
[0084] About 30 μL of blood was collected in the same manner as above 30, 60, 90, 120, and 180 minutes after the administration of sucrose. Plasma was obtained from the collected blood and stored frozen, and the plasma glucose concentration was measured later.
[0085] The statistical analysis of the results was performed by Tukey test based on the mean and standard deviation, and the significant difference was determined at a risk ratio of P < 0.05.
[0086] 5. Test results
[0087] (1) Changes in blood sugar levels over time
[0088] Based on the time-dependent measurement results of blood sugar levels, the time-dependent changes in blood sugar levels and the blood sugar levels at each measurement time minus the blood sugar levels before administration of the test substance = Δ time-dependent changes were calculated, and the blood sugar change chart was prepared by plotting the results. Figure 1 ), Δ time-dependent changes ( Figure 2 ).
[0089] like Figure 1 , Figure 2 As shown, the composition of the present invention can suppress the increase of blood sugar almost as well as the pharmaceutical acarbose. Interestingly, unlike the known prior art information, the camellia extract (Camellia) hardly observed the phenomenon of suppressing the increase of blood sugar level. This can be more clearly confirmed in the graph of Δ change over time.
[0090] In addition, by blending three ingredients: camellia extract, mulberry leaf extract, and chitosan, the rise in blood sugar levels after meals can be significantly inhibited.
[0091] (2) Sugar Absorption
[0092] In order to confirm the amount of sugar absorbed, AUC and ΔAUC were calculated from the graph of time-dependent changes and are shown in Figure 3 , Figure 4 From AUC and ΔAUC, it is clear that the composition of the present invention can significantly inhibit the absorption of sugars almost as much as the pharmaceutical acarbose.
[0093] It is also interesting that camellia extract (Camellia sinensis) does not inhibit sugar absorption, contrary to known prior art information. Figure 3 , Figure 4 As shown, by blending camellia extract, mulberry leaf extract, and chitosan, the absorption of sugar can be significantly inhibited.
[0094] <2. Human clinical trials (1)>
[0095] The effect of the composition of the present invention on suppressing the increase in postprandial blood sugar level was tested through clinical trials on humans.
[0096] Test methods
[0097] 1. Subject
[0098] (1) Selection criteria
[0099] 1) Japanese male or female adult aged 20 years or older and under 65 years old (age is based on the date of obtaining consent)
[0100] 2) Fasting blood sugar level is below 125 (mg / dL)
[0101] 3) Those whose blood sugar level is 140 (mg / dL) or above 30 minutes or 60 minutes after taking a stressful food
[0102] 4) Those whose blood sugar level is below 199 (mg / dL) 120 minutes after taking the food that causes stress
[0103] 40 adult men and women who met the above conditions were selected as subjects.
[0104] Furthermore, 40 subjects were randomly divided into Group A and Group B (20 subjects per group, 2 groups in total).
[0105] 2. Test food
[0106] (1) Tablets (CAL) of the food to be tested
[0107] (In each intake of 3 tablets) Preparation: Mulberry leaf extract (dried) 200 mg
[0108] Chitosan 100mg
[0109] Camellia extract (dry substance) 60mg
[0110] To prepare other tablets, the following ingredients were formulated as excipients.
[0111] Cellulose, starch, hydroxypropyl cellulose, silicon dioxide, calcium stearate, shellac, unbaked shell calcium, coloring (placebo only), dibasic calcium phosphate.
[0112] (2) Tablets formed by compression of placebo food (p)
[0113] Only the above-mentioned excipients are compressed into tablets.
[0114] 3. Sugary substances load
[0115] After taking the test food or placebo, the subjects took 200 g of high-temperature sterilized rice (Japanese product name: "サトウのごはん (Chinese translation: Sato's rice)") as a sugar load. In addition, the nutritional components of rice are as follows.
[0116] [Table 2]
[0117] (200g)
[0118] Element Sugary substances (g) 67.8 Dietary fiber (g) - Protein (g) 4.2 Lipid (g) 0 Energy (kcal) 294
[0119] As for the sugar load, after blood was collected on an empty stomach, the food to be tested was taken with 150 ml of water, and 10 minutes later, 200 g of "Sato's Rice" was taken with 150 ml of water within 10 minutes. After starting to take rice, blood was collected at 30 minutes, 60 minutes, and 120 minutes. In addition, the test was divided into Phase I and Phase II, and a crossover test was set up in which the subjects took both the food to be tested and the placebo as test foods (leaving a blank period of more than 4 days). In addition, the blood samples collected were used to measure blood sugar and insulin levels.
[0120] Test results
[0121] Figure 5 A graph showing the results of blood sugar level measurement, Figure 6 A graph showing the results of insulin measurement.
[0122] Compared with the case of taking the placebo (P), the blood glucose level after 30 minutes and 60 minutes of rice loading and the AUC until 120 minutes were significantly lower when taking the test food (CAL). The same results were obtained for insulin. Therefore, it can be confirmed that the composition of the present invention can inhibit the increase of blood glucose level after a meal in humans.
[0123] <3. Human clinical trials (2)>
[0124] The effect of the composition of the present invention on suppressing the increase of triglyceride in blood after a meal was tested through human clinical trials.
[0125] Test methods
[0126] In the same manner as the test for suppressing the increase in postprandial blood sugar level, a lipid loading test was performed to measure the triglyceride in the postprandial blood. Separately, a lipid loading food having the following composition was prepared.
[0127] (1) Preparation of lipid-loaded foods
[0128] Corn cream soup (butter (Yotsuba butter, salt-free, Yotsuba Dairy Co., Ltd.) 20.0 g and lard (lard, Snow Brand Dairy Co., Ltd.) 13.9 g were dissolved in 200.0 g of corn soup (corn cream soup, Nagoya Cheese Co., Ltd.) and mixed (total fat mass 40.0 g) and used as a lipid-loaded food.
[0129] Test results
[0130] Figure 7 A graph showing the results of triglyceride measurement.
[0131] When the test food (CAL) was ingested, the blood triglyceride levels 2, 3, 4, and 6 hours after lipid loading and the AUC until 6 hours after lipid loading were significantly lower than those when the placebo (p) was ingested.
[0132] Therefore, it was confirmed that the composition of the present invention can suppress the increase in postprandial blood sugar level in humans.
[0133] In addition, there were no health issues with the subjects in clinical trials (1) and (2).
Claims
1. A composition for suppressing a postprandial increase in blood sugar level and / or a postprandial increase in blood triglyceride, characterized in that: Contains camellia extract, mulberry leaf extract and chitosan as active ingredients; The invention comprises 2 to 4 parts by mass of a dried mulberry leaf extract and 1 to 2 parts by mass of chitosan per 1 part by mass of a dried camellia extract. Contains 50~250mg of dried camellia extract, 100~500mg of dried mulberry leaf extract, and 50~500mg of chitosan. The camellia extract and mulberry leaf extract are respectively extracted from camellia and mulberry leaves with water or lower alcohol; the camellia extract contains more than 1.5% by mass of camellia saponins as total saponins.
2. The composition according to claim 1, characterized in that To be consumed immediately before a meal.
Citation Information
Patent Citations
Diet food
JP2004194635A
Ingredient of tea blossom and its use
JP2006070018A
Component including flower part of tea plant or assam tea plant, and use thereof
JP2008024654A
Bowel motion-enhancing action and pancreatic lipase-inhibiting action ingredient of tea flower and its application
JP2009057365A
Tea flower ingredient for suppressing discharge function of stomach and its use
JP2009249374A
